Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-30 Purchase | 2021-04-01 6:16 pm | Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson | 25,000 | $20 | $500,000 | 154,923 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-24 5:00 pm | N/A 2034-06-19 | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-06-13 Gift | 2024-06-17 6:39 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director | 1,332,900 | $0 | 4,824,554 (Indirect) | View |
| 2024-06-07 Gift | 2024-06-07 9:11 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director 10% Owner | 1,332,950 | $0 | 6,157,454 (Indirect) | View |
| 2024-06-04 Other(A) | 2024-06-07 9:09 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner | 2,665,800 | $0 | 10,156,204 (Indirect) | View |
| 2024-06-04 Other | 2024-06-06 4:32 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner | 2,665,800 | $0 | 3,998,700 (Indirect) | View |
| 2024-06-04 Gift | 2024-06-06 4:32 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner | 1,332,900 | $0 | 3,998,700 (Indirect) | View |
| 2023-09-01 Option Award | 2023-09-05 5:33 pm | N/A 2033-08-31 | Design Therapeutics Inc. | DSGN | Shah Pratik President, CEO and Chairperson | 2,100,000 | $0 | 2,100,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-28 9:00 pm | N/A 2033-06-26 | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:40 pm | N/A 2033-01-31 | Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson | 415,000 | $0 | 415,000 (Direct) | View |
| 2022-11-08 Option Award | 2022-11-10 6:00 pm | N/A 2031-11-30 | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner | 10,510,774 | $0 | 10,510,774 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 7:50 pm | N/A 2032-01-31 | Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson | 475,000 | $0 | 475,000 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:16 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson | 275,948 | $0 | 154,923 (Indirect) | View |
Ownership | 2021-03-25 9:09 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson | 0 | $0 | 104,923 (Indirect) | View |
| 2020-01-23 Disposition | 2020-01-24 6:38 pm | N/A 2029-06-06 | Synthorx Inc. | THOR | Shah Pratik Director | 10,223 | $55.6 | 0 (Direct) | View |
| 2020-01-23 Equity Swap | 2020-01-24 6:38 pm | N/A N/A | Synthorx Inc. | THOR | Shah Pratik Director | 62,412 | $68 | 0 (Direct) | View |